Msd Partners, L.P. Alaunos Therapeutics, Inc. Transaction History

Msd Partners, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Jun 22, 2023	SELL	$0.62 - $1.17 $18.8 Million - $35.5 Million	-30,303,032 Reduced 66.67%	15,151,516 $9.85 Million
Q4 2021 Jun 22, 2023	BUY	$1.09 - $1.89 $33 Million - $57.3 Million	30,303,032 Added 200.0%	45,454,548 $49.5 Million
Q3 2019 Nov 14, 2019	BUY	$4.13 - $6.94 $17.2 Million - $28.9 Million	4,165,258 Added 37.91%	15,151,516 $64.8 Million
Q4 2018 Mar 04, 2019	BUY	$1.61 - $3.62 $12.2 Million - $27.4 Million	7,575,758 Added 222.13%	10,986,258 $20.5 Million
Q3 2017 Nov 14, 2017	BUY	$4.99 - $6.57 $17 Million - $22.4 Million	3,410,500	3,410,500 $20.9 Million

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $424M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Msd Partners, L.P., based on Form 13F filings with the SEC.

Stay updated on Msd Partners, L.P. with notifications on news.